CRCM  Vol.4 No.9 , September 2015
Esthesioneuroblastoma Masquerading as Chronic Rhinosinusitis
ABSTRACT
Background: Esthesioneuroblastoma, a rare tumour of the nasal vault, can present with symptoms that can be mistaken for common conditions such as chronic rhinosinusitis or recurrent epistaxis. Case presentation: A 52-year-old, previously healthy, Caucasian female presented to the emergency room with two months of nasal congestion and a spontaneous, protracted nosebleed that required a nasal clamp to settle. In the following months she had another episode of epistaxis in addition to fatigue, headaches, anosmia, difficulty breathing, worsening vision, weight loss and behavioral changes. Subsequent investigations led to the diagnosis of esthesioneuroblastoma. Conclusion: When patients present with recurrent epistaxis or chronic rhinosinusitis that does not respond to a reasonable course of medical therapy and/or have atypical associated symptoms, further investigations should be considered. The presences of red flags, such as weight loss, severe headaches, vision changes or bizarre behavior are also clues that alternate diagnoses and further additional workup should be considered.

Cite this paper
McCulloch, S. , Y. Lau, H. , Starreveld, Y. , Lysack, J. and Hao, D. (2015) Esthesioneuroblastoma Masquerading as Chronic Rhinosinusitis. Case Reports in Clinical Medicine, 4, 303-308. doi: 10.4236/crcm.2015.49060.
References
[1]   Bradley, P.J., Jones, N.S. and Robertson, I. (2003) Diagnosis and Management of Esthesioneuroblastoma. Current Opinion in Otolaryngology & Head & Neck Surgery, 11, 112-118.
http://dx.doi.org/10.1097/00020840-200304000-00009

[2]   Broich, G., Pagliari, A. and Ottaviani, F. (1997) Esthesioneuroblastoma: A General Review of the Cases Published since the Discovery of the Tumour in 1924. Anticancer Research, 17, 2683-2706.

[3]   Kairemo, K.J., Jekunen, A.P., Kestila, M.S. and Ramsay, H.A. (1995) Imaging of Olfactory Neuroblastoma—An Analysis of 17 Cases. Auris Nasus Larynx, 25, 173-179.
http://dx.doi.org/10.1016/S0385-8146(98)00003-0

[4]   Jethanamest, D., Morris, L.G., Sikora, A.G. and Kutler, D.I. (2007) Esthesioneuroblastoma: A Population-Based Analysis of Survival and Prognostic Factors. Archives of Otolaryngology—Head & Neck Surgery, 133, 276-280.
http://dx.doi.org/10.1001/archotol.133.3.276

[5]   Dulguerov, P., Allal, A.S. and Calcaterra, T.C. (2001) Esthesioneuroblastoma: A Meta-Analysis and Review. The Lancet Oncology, 2, 683-690.
http://dx.doi.org/10.1016/S1470-2045(01)00558-7

[6]   Broski, S.M., Hunt, C.H., Johnson, G.B., Subramaniam, R.M. and Peller, P.J. (2012) The Added Value of 18F-FDG PET/CT for Evaluation of Patients with Esthesioneuroblastoma. Journal of Nuclear Medicine, 53, 1200-1206.
http://dx.doi.org/10.2967/jnumed.112.102897

[7]   Benfari, G., Fusconi, M., Ciofalo, A., Gallo, A., Altissimi, G., Celani, T. and De Vincentiis, M. (2008) Radiotherapy Alone for Local Tumor Control in Esthesioneuroblastoma. Acta Otorhinolaryngologica Italica, 28, 292-297.

[8]   Ow, T.J., et al. (2014) Optimization of Long Term Outcomes for Patients with Esthesioneuroblastoma. Head & Neck, 36, 524-530.
http://dx.doi.org/10.1002/hed.23327

[9]   Modesto, A., et al. (2013) Multimodal Treatment and Long-Term Outcome of Patients with Esthesioneuroblastoma. Oral Oncology, 49, 830-834.
http://dx.doi.org/10.1016/j.oraloncology.2013.04.013

[10]   Eden, B.V., Debo, R.F., Larner, J.M., Kelly, M.D., Levine, P.A., Stewart, F.M., Cantrell, R.W. and Constable, W.C. (1994) Esthesioneuroblastoma: Long-Term Outcome and Patterns of Failure—The University of Virginia Experience. Cancer, 73, 2556-2562.
http://dx.doi.org/10.1002/1097-0142(19940515)73:10<2556::AID-CNCR2820731017>3.0.CO;2-S

[11]   McElroy Jr., E.A., Buckner, J.C. and Lewis, J.E. (1998) Chemotherapy for Advanced Esthesioneuroblastoma: The Mayo Clinic Experience. Neurosurgery, 42, 1023-1027.
http://dx.doi.org/10.1097/00006123-199805000-00040

[12]   Polin, R., Sheehan, J., Chenelle, A., Munoz, E., Larner, J. and Phillips, C. (1998) The Role of Preoperative Adjuvant Treatment in the Management of Esthesioneuroblastoma: The University of Virginia Experience. Neurosurgery, 42, 1029-1037.
http://dx.doi.org/10.1097/00006123-199805000-00045

[13]   Bachar, G., Goldstein, D.P., Shah, M., Tandon, A., Ringash, J., Pond, G., Gullane, P.J., Perez-Ordonez, B., Gilbert, R.W., Brown, D.H., Gentili, F., O’Sullivan, B. and Irish, J.C. (2008)Esthesioneuroblastoma: The Princess Margaret Hospital Experience. Head & Neck, 30, 1607-1614.
http://dx.doi.org/10.1002/hed.20920

[14]   Rimmer, J., et al. (2014) Olfactory Neuroblastoma: A 35-Year Experience and Suggested Follow-Up Protocol. Laryngoscope, 124, 1542-1549.
http://dx.doi.org/10.1002/lary.24562

 
 
Top